CG
TECH icon

Cutler Group’s Bio-Techne TECH Stock Holding History

Cutler Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-800
Closed -$49K – 5476
2020
Q3 		$49K Hold
800
– – ﹤0.01% 1814
2020
Q2 		$52K Buy
+800
New +$47.9K ﹤0.01% 1715
2018
Q3 		– Sell
-2,000
Closed -$73K – 4678
2018
Q2 		$73K Sell
2,000
-400
-17% -$15.3K 0.01% 1364
2018
Q1 		$90K Buy
+2,400
New +$84.8K 0.01% 1257

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cutler Group's TECH Position: Q4 2020 in Review

Cutler Group sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 800 shares — an estimated $49K sold.

Cutler Group first reported a position in TECH in Q1 2018 and held it in 4 quarters. The position peaked at $90K in Q1 2018. 441 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

  • Cutler Group reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
  • Cutler Group sold 800 Bio-Techne shares in Q4 2020, an estimated $49K.
  • Cutler Group first reported a position in Bio-Techne in Q1 2018 and held it in 4 quarters.
  • Cutler Group's Bio-Techne position peaked at $90K in Q1 2018.
  • 441 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.